HOME > BUSINESS
BUSINESS
- Shionogi Licenses Cognitive Disorders Treatment Candidate from Tetra
December 20, 2018
- Shonan iPark Sets Up Consortium for Commercializing Disease Prevention
December 20, 2018
- Otezla Reduces Oral Ulcers in Japanese Behcet’s Disease Patients in PIII Study: Celgene
December 20, 2018
- Takeda Likely to Make NYSE Debut on Christmas Eve
December 19, 2018
- Bristol-Myers, Eisai Unit Ink I/O Collaboration
December 19, 2018
- Daiichi Sankyo Grants ROS1/NTRK Inhibitor Rights to AnHeart
December 19, 2018
- Shionogi Earns CHMP OK for Naldemedine
December 19, 2018
- Novo Links with H2 Inc. for Diabetes Treatment App
December 19, 2018
- Takeda, Alphabet's Health Unit Team Up on Japanese Parkinson’s Patient Research
December 19, 2018
- Adcetris Label Expansion Gets European Panel Nod: Takeda
December 18, 2018
- Hisamitsu Files Asenapine Transdermal Patch for Schizophrenia in US
December 18, 2018
- Eisai Grants to Eurofarma Exclusive Rights for Obesity Agent Lorcaserin in Brazil
December 18, 2018
- Efficacy of Fentos Tape for Cancer Pain in Opioid-Naïve Patients Confirmed in PIII Study: Hisamitsu
December 17, 2018
- Janssen Applies for Darzalex for Previously Untreated Multiple Myeloma Patients
December 17, 2018
- Gilead Files HIV Triplet Biktarvy in Japan, JT Pact Termination Set for Jan. 1
December 17, 2018
- Astellas Makes Full Inroads into I/O Arena with Potenza Buyout
December 17, 2018
- Lundbeck Japan to Quadruple Workforce by Next Summer, Eyes Vortioxetine Launch: Chief
December 14, 2018
- Astellas CEO Sees Cell Therapy Biz Model Established by “around 2030”
December 14, 2018
- ASKA to Review 5-Year Biz Plan after Hit by NHI Price Cut, Despite New Drug Launches
December 14, 2018
- Daiichi Sankyo Mulling Moving Up DS-8201 Filing to FY2019: Oncology Chief
December 13, 2018
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
